MPM BioImpact LLC 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:09 pm Sale | 2025-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | MPM BioImpact LLC | 10,679,391 11.600% | -4,026,491 (-27.38%) | Filing |
| 2025-01-08 4:07 pm Purchase | 2024-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | MPM BioImpact LLC | 14,705,882 16.400% | 14,705,882 (New Position) | Filing |